News

420 with CNW — FDA Publishes Final Guidance for Cannabis Drug Development

Earlier this week, the FDA published its final guidance on cannabis drug development in the federal register. This comes after it released a draft version in 2020. The guidance outlines the basic clinical study standards, considerations for researchers and the drug development process. The legalization of hemp in the 2018 Farm Bill is one major reason for the guidance’s release… The post 420 with CNW — FDA Publishes Final Guidance for Cannabis Drug Development appeared first on Cannabis Daily.


420 with CNW — Study Shows Cannabis Boosts Sex Quality for All Genders

In a recent study, participants reported that cannabis increased their desire, intensified their orgasms, and sharpened their sensory perception, providing evidence that cannabis can improve sex. Moser Amanda, a sexologist residing in Denver who has specialized in integrating cannabis and sex, took part as the paper’s lead author. More than 70% of respondents to Moser’s online questionnaire, which included more… The post 420 with CNW — Study Shows Cannabis Boosts Sex Quality for All Genders appeared first on Cannabis Daily.


The Global Cannabis Stock Index Jets Higher in January

From the deeply depressed year-end 2022 close of 9.71, the Global Cannabis Stock Index rose 10.1% in January to 10.69. The index fell 23.7% in Q3 and 13.8% in Q4, ending 2022 down 70.4%: Since the peak in February 2021, the Global Cannabis Stock Index has dropped 88.4% from the 92.48 closing high: The strongest 4 names […] READ MORE: https://www.newcannabisventures.com/the-global-cannabis-stock-index-jets-higher-in-january/ The post The Global Cannabis Stock Index Jets Higher in January appeared first on Cannabis Daily.


Silo Pharma Announces Stock Repurchase Program

ENGLEWOOD CLIFFS, NJ, Jan. 31, 2023 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that its board of directors has authorized a share repurchase program to acquire up to $1,000,000 of the Company’s common stock. The Company may purchase common stock in the open market, through privately… The post Silo Pharma Announces Stock Repurchase Program appeared first on Cannabis Daily.


Nextleaf Announces Fiscal 2022 Results and Provides Commentary

Nextleaf Announces Fiscal 2022 Results and Provides Commentary

Vancouver, British Columbia–(Newsfile Corp. – January 31, 2023) – Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf“, “OILS“, or the “Company“), a federally regulated manufacturer and distributor of cannabis extracts, has released its audited annual financial statements for the fiscal year ended September 30, 2022. Nextleaf is pleased to provide a summary of selected financial highlights and milestones… The post Nextleaf Announces Fiscal 2022 Results and Provides Commentary appeared first on Cannabis Daily.